论文部分内容阅读
作者对30名由于各种原因所致的室性、房性期前收缩及房颤患者采用内服乙胺碘呋酮(Amiod-arone)、安定(Valium)及阿托品(Atropine)伍用的方法(简称 AVA 疗法),获得了较为显著的疗效,报导如下。对象与方法本组共观察各种心律失常患者30例。其中男性16名,女性14名。平均年龄39岁(21—60岁)。冠心病3例,高血压病3例,心肌炎1例。其余23例均无明显器质性心脏病表现。室性期前收缩23例,属频发性者有18例,其中1例系多源性者。房性期前收缩5例。房颤2例。罹心律失常时间为1周至4年(平均248天)。另有一组23例风湿性心脏瓣
The authors of 30 due to various reasons, ventricular, atrial premature contractions and atrial fibrillation patients with oral administration of amiodarone (Amiodarone, Valium and Atropine) Referred to as AVA therapy), access to a more significant effect, reported as follows. Objects and Methods This group were observed in a variety of patients with arrhythmia in 30 cases. Among them, 16 males and 14 females. The average age is 39 years old (21-60 years old). 3 cases of coronary heart disease, 3 cases of hypertension, myocarditis in 1 case. The remaining 23 cases showed no obvious organic heart disease performance. Premature ventricular contraction in 23 cases, is a frequent case of 18 cases, of which 1 case of multi-source. Atrial contraction in 5 cases. Atrial fibrillation in 2 cases. Arrhythmia times range from 1 week to 4 years (average, 248 days). Another group of 23 rheumatic heart valves